Evidence-Based Clinical Pharmaceutical Methods
Syllabus, Master's level, 3FB505
- Code
- 3FB505
- Education cycle
- Second cycle
- Main field(s) of study and in-depth level
- Clinical Pharmacy A1F
- Grading system
- Pass with distinction (VG), Pass (G), Fail (U)
- Finalised by
- The Educational Board of Pharmacy, 20 April 2023
- Responsible department
- Department of Pharmacy
Entry requirements
Admitted to the Master's programme in Clinical Pharmacy.
Learning outcomes
After examination, the student should be able to:
- handle different methods and tools to practise clinical pharmacy
- briefly explain the structure of the healthcare and interpret the laws, rules and constitutions that govern the pharmacist within healthcare
- discuss ethical concepts and dilemmas relevant to clinical pharmacy
- formulate a searchable question, carry out searches in databases and identify relevant and scientific information about drugs.
- critically review and evaluate clinical pharmaceutical studies, systematic reviews and meta-analyses, assess the weighted evidence and apply this in the evaluation of a patient's therapy
- report tasks in a structured manner, orally and in writing, in good Swedish
Content
The course focuses on evidence-based medicine. It addresses working methods and tools for clinical pharmaceutical work, such as communication, meeting patients and ethics. Furthermore, information search, critical review of studies and evaluation of evidence in relation to the patient's drug treatment are discussed.
Instruction
Teaching is given as lectures, oral and written reports, workshops, discussion seminars, peer exercises and self-study. Some parts of the teaching may be online and given in English.
Compulsory parts: Oral and written presentation of patient cases, workshops and discussion seminars about evidence-based methods and the organisation of health care, preparatory lectures before clincial experience (VFU) and communication training.
Assessment
For a passing grade the student must pass the written EBM case (6 hp) and have approved results on other compulsory exercises 1 (4,5 hp), 2 (1,5 hp) and 3 (0 hp).
The possibility of supplementing unapproved compulsory parts can be prepared at the earliest at the next course session and only subject to availability. If there are special reasons for doing so, an examiner may make an exception from the method of assessment indicated and allow a student to be assessed by another method. An example of special reasons might be a certificate regarding special pedagogical support from the University's disability coordinator.
Other regulations
This course replaces and corresponds to the clinical introduction sub-courses. Clinical introduction, Evidence-based medicine and pharmacy and Patient-centred work and communication skills within course 3FB005 Master's programme with breadth in clinical pharmacy.
This course substitutes and corresponds to 3FB501, Evidence-Based Clinical Pharmaceutical Methods.